Financial & Corporate Governance
Investor Relations
G.D. Pharmaceuticals Limited has proposed offering its shares to the general public. This section will host our prospectus, financial statements, general meeting notices and IPO updates.
GDPL
Market symbol
IPO proposed
Status
SEBON
Regulator
WHO-GMP
Manufacturing standard
Financial Disclosures & Reports
Statutory documents, audit reports and investor notices filed under SEBON and company registrar requirements.
Notice of Special General Meeting
31 May 2026
Prospectus
After SEBON approval
Audited financial statements
To be published
Annual General Meeting notices
To be published
Shareholder Registry
For queries about share certificates, transfers, general meeting notices or a change of address:
Had a side effect from one of our medicines?
Tell us. Every report helps us keep our products safe. In an emergency, see a doctor first.